Saturday, October, 20, 2018 02:32:07

Category: Health

Cobra Biologics with GE Healthcare and CPI to develop AAV vectors

Cobra Biologics, an international biologics and pharmaceuticals contract development and manufacturing organization recently announced that it will be collaborating with UK-based technology innovation foundation, Centre for Process Innovation (CPI) and GE Healthcare Life Sciences. The aim of the three-way partnership is to increase the strength …

Tris Pharma acquires NextWave Pharmaceuticals, expands ADHD portfolio

Tris Pharma, technology-based therapeutic products developer recently acquired NextWave Pharmaceuticals, a subsidiary of Pfizer, the American pharmaceutical corporation. The sum involved in the acquisition has not been disclosed. According to reliable sources, the acquisition will enable Tris Pharma to expand its product offering in the …

Ariel launches genomic tool for early diagnosis of pancreatic illness

Ariel Precision Medicine Inc., a Pennsylvania-based digital health care company, has reportedly announced the launch of a new cloud-based genomic tool ArielDx® that would simplify diagnosis and treatment of pancreatic diseases. Reports cite, ArielDx is already available for purchase on the company’s website through prescription …

Roche announces global availability of FoundationOne®Liquid

Roche AG, a Swiss multinational healthcare company has recently announced the availability of a next-gen liquid biopsy test, FoundationOne®Liquid. The Swiss company also claims that the liquid biopsy would offer patients suffering with solid tumors a quick and convenient testing option, just by diagnosing a single …

Amicus Therapeutics cuts deal with Celenex, enters gene therapy

Amicus Therapeutics has recently unveiled that it has acquired Celenex, a clinical-stage gene therapy company and a spin out of the Ohio-based Nationwide Children’s Hospital, in a multimillion dollar deal. Reportedly, the deal expands Amicus portfolio of 10 gene therapy programs that are originally discovered …

Biopharma giant Merck inaugurates $20 million lab in Singapore

Merck, the Germany-based multinational biopharmaceutical, chemical and life sciences company, has reportedly announced to have opened a $20 million lab in Singapore. Reports cite, the laboratory would be constructed near Pasir Panjang. Spanning over an area of 3,800 square feet, the facility would be housing …